Completed PHASE4 INTERVENTIONAL 4-arm NCT05431218

Association of Cathelicidin and Vitamin D Levels With the Category and Course of COPD (COPD)

Sponsor: Karaganda Medical University

Conditions Chronic Obstructive Pulmonary Disease Chronic Obstructive Pulmonary Disease Moderate Chronic Obstructive Pulmonary Disease Severe

Interventions Cholecalciferol Liquid

Updated 4 times since 2022 Last updated: Apr 11, 2024 Started: Feb 18, 2020 Primary completion: Dec 30, 2021 Completion: Dec 31, 2021

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE4 trial investigates Chronic Obstructive Pulmonary Disease and Chronic Obstructive Pulmonary Disease Moderate and is currently completed. Karaganda Medical University leads this study, which shows 4 recorded versions since 2020 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

4 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
May 2024 — Jul 2024 [monthly]

Completed PHASE4
Jul 2022 — May 2024 [monthly]

Completed PHASE4

First recorded

Feb 2020

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Karaganda Medical University

Data source: Karaganda Medical University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Karaganda, Kazakhstan